The heat fell hard on Wall Street in July 2025. The S&P 500, that grand collection of American enterprise, moved like a storm-tossed ship. Some stocks climbed the rigging toward bright skies. Others fell, their sails torn and masts broken.
The Fallers of July
Near the bottom lay Deckers Outdoor. Their brands—UGG, Hoka, Teva—were once names spoken with warmth and comfort. But in 2025, their shares were cut in half. The year’s brutal toll left Deckers one of the worst-performing stock in the S&P 500 by July. Investors saw a company battered by shifting tariffs and a fickle market. The wind that once filled their sails turned to a howling gale that snapped them low.
UnitedHealth Group, a titan in healthcare, did not escape the storm either. Shares plunged by over 40 percent. The company, once a beacon of steady growth, stumbled under the weight of rising claim costs, regulatory scrutiny, and a sudden loss of its CEO. Analysts cut their ratings like a swift knife. The future looked uncertain, and investors felt the bite of sharp losses.
Centene, another healthcare giant, sailed into rough waters as well. Its stock lost over half its value through 2025. The healthcare sector, usually a refuge in choppy markets, was battered by slowing growth and worries about profitability. Centene’s fall was steep, casting a shadow over the hopes of those who held its shares.
Stocks That Climbed Against the Wind
Yet not all were prisoners of the storm. Some stocks climbed, stubborn and stalwart. AMD, the chipmaker, found strength in the rising demand for processors. Their shares rallied, defiant against the market's turbulence. GE Vernova, tied to the old giant that powered America, also gained ground, bolstered by energy and industrial hope.
These winners reminded investors that laws of survival endure in business as in nature. When the tide rolls out, some ships sink, but others push forward, ripping through the waves with steady resolve. AMD and GE Vernova showed that resilience can come from innovation and solid footing in essential industries.
The Broader Picture
The S&P 500 itself told a tale of recovery and struggle. After flirting with bear market territory early in the year, the index bounced back to post a gain of about 6.6 percent by mid-2025. But this rise was a mask over uneven fortunes beneath the surface. Many stocks remained beaten down, their futures cloudy, their charts stained red.
Technology stocks like Enphase Energy faced deep setbacks. Once the darlings of solar energy, their shares dropped over 50 percent. The green dream dimmed for some, as market realities and shifting policies weighed heavy. Biotechnology stocks fared no better. Sarepta Therapeutics fell by more than 70 percent in the second quarter. A harsh reminder that promises of breakthrough medicine do not always keep their word.
Such volatility pointed to an economy in flux. Trade policies shifted like sea winds. Healthcare costs rose like an unforgiving tide. Inflation and interest rates cast long shadows. Investors navigated an uncertain world, hoping to find safe harbor but fearing the next wave.
July 2025 was a month of brutal lessons. It was a month when the giants of Wall Street showed their cracks. And it was a month when those who endured did so not through luck, but steadfast will.
